Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies.
Saved in:
| Title: | Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies. |
|---|---|
| Authors: | Phillip M; Institute for Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Mathieu C; Clinical and Experimental Endocrinology, University of Leuven, Leuven, Belgium., Lind M; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine, NU-Hospital Group, Uddevalla, Sweden., Araki E; Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan., di Bartolo P; Ravenna Internal Medicine Department, Ravenna Diabetes Clinic, Romagna Local Health Authority, Ravenna, Italy., Bergenstal R; International Diabetes Center, Health Partners Institute, Minneapolis, Minnesota, USA., Heller S; Department of Oncology and Metabolism, University of Sheffield School of Medicine, Sheffield, UK., Hansen L; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Scheerer MF; BioPharmaceuticals Medical, AstraZeneca, Wedel, Germany., Thoren F; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Arya N; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Xu J; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Iqbal N; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA., Dandona P; Department of Endocrinology, Kaleida Health, Buffalo, New York, USA. |
| Corporate Authors: | DEPICT-1 and DEPICT-2 Investigators |
| Source: | Diabetes, obesity & metabolism [Diabetes Obes Metab] 2021 Feb; Vol. 23 (2), pp. 549-560. Date of Electronic Publication: 2020 Nov 24. |
| Publication Type: | Clinical Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33145944 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Phillip+M%22">Phillip M</searchLink>; Institute for Endocrinology and Diabetes, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.<br /><searchLink fieldCode="AU" term="%22Mathieu+C%22">Mathieu C</searchLink>; Clinical and Experimental Endocrinology, University of Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Lind+M%22">Lind M</searchLink>; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine, NU-Hospital Group, Uddevalla, Sweden.<br /><searchLink fieldCode="AU" term="%22Araki+E%22">Araki E</searchLink>; Department of Metabolic Medicine, Kumamoto University, Kumamoto, Japan.<br /><searchLink fieldCode="AU" term="%22di+Bartolo+P%22">di Bartolo P</searchLink>; Ravenna Internal Medicine Department, Ravenna Diabetes Clinic, Romagna Local Health Authority, Ravenna, Italy.<br /><searchLink fieldCode="AU" term="%22Bergenstal+R%22">Bergenstal R</searchLink>; International Diabetes Center, Health Partners Institute, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Heller+S%22">Heller S</searchLink>; Department of Oncology and Metabolism, University of Sheffield School of Medicine, Sheffield, UK.<br /><searchLink fieldCode="AU" term="%22Hansen+L%22">Hansen L</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Scheerer+MF%22">Scheerer MF</searchLink>; BioPharmaceuticals Medical, AstraZeneca, Wedel, Germany.<br /><searchLink fieldCode="AU" term="%22Thoren+F%22">Thoren F</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Arya+N%22">Arya N</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Xu+J%22">Xu J</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Iqbal+N%22">Iqbal N</searchLink>; BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Dandona+P%22">Dandona P</searchLink>; Department of Endocrinology, Kaleida Health, Buffalo, New York, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22DEPICT-1+and+DEPICT-2+Investigators%22">DEPICT-1 and DEPICT-2 Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2021 Feb; Vol. 23 (2), pp. 549-560. <i>Date of Electronic Publication: </i>2020 Nov 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Study; Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33145944 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/dom.14248 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 549 Titles: – TitleFull: Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Phillip M – PersonEntity: Name: NameFull: Mathieu C – PersonEntity: Name: NameFull: Lind M – PersonEntity: Name: NameFull: Araki E – PersonEntity: Name: NameFull: di Bartolo P – PersonEntity: Name: NameFull: Bergenstal R – PersonEntity: Name: NameFull: Heller S – PersonEntity: Name: NameFull: Hansen L – PersonEntity: Name: NameFull: Scheerer MF – PersonEntity: Name: NameFull: Thoren F – PersonEntity: Name: NameFull: Arya N – PersonEntity: Name: NameFull: Xu J – PersonEntity: Name: NameFull: Iqbal N – PersonEntity: Name: NameFull: Dandona P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2021 Feb Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1463-1326 Numbering: – Type: volume Value: 23 – Type: issue Value: 2 Titles: – TitleFull: Diabetes, obesity & metabolism Type: main |
| ResultId | 1 |